Dividend History
| Pay Date | Amount | Ex-Date | Record Date |
|---|---|---|---|
| April 23, 2026 | $0.60 | 2026-04-07 | 2026-04-07 |
| May 15, 2025 | $0.60 | 2025-04-29 | 2025-04-29 |
| April 11, 2024 | $0.60 | 2024-03-25 | 2024-03-26 |
| June 1, 2023 | $0.45 | 2023-05-15 | 2023-05-16 |
| June 2, 2022 | $0.45 | 2022-05-16 | 2022-05-17 |
Dividends Summary
- Consistent Payer: has rewarded shareholders with 5 dividend payments over the past 4 years.
- Total Returned Value: Investors who held SIGA shares during this period received a total of $2.70 per share in dividend income.
- Latest Payout: The most recent dividend of $0.60/share was paid 86 days ago, on April 23, 2026.
- Yield & Schedule: SIGA currently pays dividends yearly with an annual yield of 17.44%.
- Dividend Growth: Since 2022, the dividend payout has grown by 33.3%, from $0.45 to $0.60.
- Dividend Reliability: SIGA has maintained or increased its dividend for 5 consecutive payments.
Company News
SIGA Technologies reported Q1 2026 results with minimal product deliveries ($6M total revenue, $3M net loss) but highlighted strong forward momentum including a $13M Asia-Pacific oral TPOXX order expected in Q2, a new exclusive distribution agreement with Hikma for the Middle East and North Africa region, and ongoing development of pediatric and ...
SIGA Technologies announced a special cash dividend of $0.60 per share, payable on April 23, 2026, to shareholders of record as of April 7, 2026. The dividend amount matches the special dividend declared in April 2025. CEO Diem Nguyen stated the announcement reflects the company's strong balance sheet and commitment to shareholder value while exe...
A major clinical trial (STOMP) published in the New England Journal of Medicine found that tecovirimat, an FDA-approved smallpox drug, did not improve mpox resolution in outpatient adults with clade II mpox. The randomized, placebo-controlled study of 412 participants showed 79% clinical resolution in the tecovirimat group versus 81% in the place...
Healthcare stocks have been stagnant since April, but offer attractive dividend yields ranging from 5.3% to 7.1%. The article highlights several healthcare REITs and pharmaceutical companies with high dividend potential despite market challenges.
SIGA Technologies reported strong Q2 2025 financial performance, with revenue jumping 271.6% to $81.1 million, driven by major TPOXX antiviral therapy deliveries to U.S. government agencies. The company paid a special $0.60 per share dividend and maintained robust cash reserves.
